drugset / Trial / NCT01552850

Pharmacokinetics And Relative Bioavailability Study Of Oxycodone

NCT01552850

Phase 1 Completed 18 enrolled Pain Therapeutics
RandomizedCrossoverOpen-labelBasic science

Summary

To estimate the pharmacokinetics and relative bioavailability of oxycodone after administration of 40 mg doses of four PF-00345439 formulations and oxycodone in solution

Timeline

Start
2012-04
Primary completion
2012-06
Completion
2012-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Oxycodone Other / unclassified 40 mg Oral

Indications

No indication recorded.